In addition to the reactivation of mRNAs encoding proteins with tumor suppressor functions, EZH2 inhibition induces the expression of tumor suppressor microRNA species that are predicted or documented to negatively regulate the mRNA levels of essential MM oncogenes such as c-MYC [58,112,120], or induce drug resistance [92]. The gene discussed is EZH2; the disease is neoplasm.